HomeOXB • LON
add
Oxford BioMedica plc
Previous close
GBX 300.00
Day range
GBX 301.53 - GBX 350.00
Year range
GBX 164.29 - GBX 474.50
Market cap
324.84M GBP
Avg Volume
237.79K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 23.24M | -38.81% |
Operating expense | 26.27M | -19.77% |
Net income | -54.77M | -701.04% |
Net profit margin | -235.67 | -1,209.28% |
Earnings per share | — | — |
EBITDA | -13.69M | -53.81% |
Effective tax rate | 3.44% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 103.72M | -26.60% |
Total assets | 252.34M | -45.16% |
Total liabilities | 174.51M | -22.09% |
Total equity | 77.83M | — |
Shares outstanding | 96.80M | — |
Price to book | 3.95 | — |
Return on assets | -17.22% | — |
Return on capital | -22.95% | — |
Cash Flow
Net change in cash
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -54.77M | -701.04% |
Cash from operations | -11.55M | -294.21% |
Cash from investing | 511.50K | -97.90% |
Cash from financing | -2.90M | 84.69% |
Net change in cash | -12.86M | -212.90% |
Free cash flow | -9.20M | -30.61% |
About
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Wikipedia
Founded
1995
Website
Employees
714